
December 2025


McKesson's Precision Care Companion initiative enhances biomarker testing and targeted therapies in community oncology, improving patient outcomes and cost efficiency.

Members of the CAR T Vision Steering Committee outline key issues around US and EU reimbursement and discuss potential solutions

An AJMC Stakeholder Interchange in Atlanta, Georgia addressed the need for collaboration to bring bispecific antibodies to the outpatient setting in multiple myeloma. Participants discussed the use of prophylactic tocilizumab, emergency department preparation, and health equity challenges.

From Trial Diversity to Telehealth: Advancing Equity and Access in Rural and Underserved Cancer Care
Experts explore advancements in telehealth and precision medicine, addressing cancer care gaps for rural and underserved populations in oncology.

Medicaid expansion has enhanced cancer care in Louisiana, boosting access to treatments like CAR T-cell therapy and improving breast cancer screening initiatives.




